Thermo Fisher Scientific Pre-Tax Profit Margin 2011-2025 | TMO
Current and historical pre-tax profit margin for Thermo Fisher Scientific (TMO) from 2011 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Thermo Fisher Scientific pre-tax profit margin for the three months ending September 30, 2025 was .
| Thermo Fisher Scientific Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-09-30 | $43.74B | $7.10B | 16.22% |
| 2025-06-30 | $43.21B | $7.01B | 16.23% |
| 2025-03-31 | $42.90B | $7.07B | 16.48% |
| 2024-12-31 | $42.88B | $7.04B | 16.41% |
| 2024-09-30 | $42.37B | $6.84B | 16.13% |
| 2024-06-30 | $42.35B | $6.86B | 16.20% |
| 2024-03-31 | $42.49B | $6.52B | 15.35% |
| 2023-12-31 | $42.86B | $6.30B | 14.70% |
| 2023-09-30 | $43.42B | $6.34B | 14.59% |
| 2023-06-30 | $43.52B | $6.17B | 14.18% |
| 2023-03-31 | $43.81B | $6.66B | 15.20% |
| 2022-12-31 | $44.92B | $7.84B | 17.44% |
| 2022-09-30 | $44.17B | $7.92B | 17.93% |
| 2022-06-30 | $42.82B | $8.50B | 19.84% |
| 2022-03-31 | $41.12B | $8.63B | 20.98% |
| 2021-12-31 | $39.21B | $8.84B | 22.55% |
| 2021-09-30 | $39.06B | $9.88B | 25.28% |
| 2021-06-30 | $38.25B | $9.95B | 26.02% |
| 2021-03-31 | $35.89B | $9.16B | 25.51% |
| 2020-12-31 | $32.22B | $7.23B | 22.44% |
| 2020-09-30 | $28.50B | $5.37B | 18.85% |
| 2020-06-30 | $26.25B | $3.94B | 15.02% |
| 2020-03-31 | $25.65B | $4.08B | 15.92% |
| 2019-12-31 | $25.54B | $4.07B | 15.94% |
| 2019-09-30 | $25.22B | $4.04B | 16.03% |
| 2019-06-30 | $24.87B | $4.03B | 16.21% |
| 2019-03-31 | $24.63B | $3.45B | 13.99% |
| 2018-12-31 | $24.36B | $3.26B | 13.39% |
| 2018-09-30 | $23.90B | $3.07B | 12.85% |
| 2018-06-30 | $23.09B | $2.74B | 11.86% |
| 2018-03-31 | $22.01B | $2.56B | 11.63% |
| 2017-12-31 | $20.92B | $2.43B | 11.61% |
| 2017-09-30 | $19.82B | $2.26B | 11.41% |
| 2017-06-30 | $19.20B | $2.21B | 11.51% |
| 2017-03-31 | $18.74B | $2.10B | 11.22% |
| 2016-12-31 | $18.27B | $2.02B | 11.08% |
| 2016-09-30 | $17.97B | $1.95B | 10.87% |
| 2016-06-30 | $17.61B | $1.99B | 11.33% |
| 2016-03-31 | $17.34B | $1.98B | 11.40% |
| 2015-12-31 | $16.97B | $1.94B | 11.41% |
| 2015-09-30 | $16.81B | $1.89B | 11.25% |
| 2015-06-30 | $16.85B | $1.96B | 11.64% |
| 2015-03-31 | $16.91B | $1.70B | 10.03% |
| 2014-12-31 | $16.89B | $2.09B | 12.36% |
| 2014-09-30 | $15.86B | $1.93B | 12.15% |
| 2014-06-30 | $14.89B | $1.71B | 11.47% |
| 2014-03-31 | $13.80B | $1.75B | 12.69% |
| 2013-12-31 | $13.09B | $1.32B | 10.08% |
| 2013-09-30 | $12.88B | $1.29B | 9.98% |
| 2013-06-30 | $12.78B | $1.26B | 9.88% |
| 2013-03-31 | $12.65B | $1.30B | 10.29% |
| 2012-12-31 | $12.51B | $1.27B | 10.14% |
| 2012-09-30 | $12.30B | $1.24B | 10.06% |
| 2012-06-30 | $12.15B | $1.21B | 9.94% |
| 2012-03-31 | $11.90B | $1.15B | 9.63% |
| 2011-12-31 | $11.56B | $1.13B | 9.80% |
| 2011-09-30 | $11.05B | $1.10B | 9.95% |
| 2011-06-30 | $10.75B | $1.12B | 10.43% |
| 2011-03-31 | $10.49B | $1.13B | 10.75% |
| 2010-12-31 | $10.39B | $1.09B | 10.47% |
| 2010-09-30 | $10.49B | $1.04B | 9.93% |
| 2010-06-30 | $10.40B | $1.00B | 9.64% |
| 2010-03-31 | $10.28B | $0.97B | 9.46% |
| 2009-12-31 | $9.91B | $0.88B | 8.88% |
| 2009-09-30 | $9.92B | $0.94B | 9.49% |
| 2009-06-30 | $9.97B | $0.95B | 9.56% |
| 2009-03-31 | $10.20B | $1.02B | 10.03% |
| 2008-12-31 | $10.50B | $1.13B | 10.74% |
| 2008-09-30 | $10.47B | $1.07B | 10.22% |
| 2008-06-30 | $10.29B | $1.05B | 10.17% |
| 2008-03-31 | $9.96B | $0.97B | 9.70% |
| 2007-12-31 | $9.75B | $0.86B | 8.82% |
| 2007-09-30 | $8.79B | $0.63B | 7.16% |
| 2007-06-30 | $7.12B | $0.46B | 6.52% |
| 2007-03-31 | $5.45B | $0.31B | 5.71% |
| 2006-12-31 | $3.79B | $0.21B | 5.51% |
| 2006-09-30 | $2.86B | $0.29B | 10.02% |
| 2006-06-30 | $2.82B | $0.28B | 9.83% |
| 2006-03-31 | $2.76B | $0.29B | 10.41% |
| 2005-12-31 | $2.63B | $0.29B | 10.86% |
| 2005-09-30 | $2.51B | $0.27B | 10.90% |
| 2005-06-30 | $2.37B | $0.28B | 11.66% |
| 2005-03-31 | $2.24B | $0.27B | 11.92% |
| 2004-12-31 | $2.21B | $0.26B | 11.75% |
| 2004-09-30 | $2.08B | $0.25B | 12.05% |
| 2004-06-30 | $1.98B | $0.24B | 12.11% |
| 2004-03-31 | $1.92B | $0.23B | 12.06% |
| 2003-12-31 | $1.90B | $0.22B | 11.69% |
| 2003-09-30 | $1.75B | $0.23B | 13.39% |
| 2003-06-30 | $1.82B | $0.24B | 13.16% |
| 2003-03-31 | $1.86B | $0.25B | 13.51% |
| 2002-12-31 | $1.85B | $0.30B | 16.39% |
| 2002-09-30 | $2.08B | $0.21B | 10.11% |
| 2002-06-30 | $2.07B | $0.19B | 9.31% |
| 2002-03-31 | $2.11B | $0.13B | 6.32% |
| 2001-12-31 | $2.19B | $0.07B | 3.29% |
| 2001-09-30 | $2.21B | $0.10B | 4.63% |
| 2001-06-30 | $2.24B | $0.14B | 6.03% |
| 2001-03-31 | $2.28B | $0.17B | 7.25% |
| 2000-12-31 | $2.28B | $0.17B | 7.23% |
| 2000-09-30 | $2.36B | $0.42B | 17.94% |
| 2000-06-30 | $2.44B | $0.43B | 17.42% |
| 2000-03-31 | $2.49B | $0.01B | 0.44% |
| 1999-12-31 | $2.47B | $0.04B | 1.54% |
| 1999-09-30 | $2.36B | $-0.15B | -6.45% |
| 1999-06-30 | $2.71B | $-0.18B | -6.46% |
| 1999-03-31 | $3.03B | $0.32B | 10.64% |
| 1998-12-31 | $3.41B | $0.39B | 11.46% |
| 1998-09-30 | $3.88B | $0.46B | 11.78% |
| 1998-06-30 | $3.81B | $0.54B | 14.09% |
| 1998-03-31 | $3.74B | $0.52B | 13.99% |
| 1997-12-31 | $3.56B | $0.49B | 13.74% |
| 1997-09-30 | $3.34B | $0.45B | 13.40% |
| 1997-06-30 | $3.17B | $0.43B | 13.49% |
| 1997-03-31 | $3.04B | $0.40B | 13.04% |
| 1996-12-31 | $2.92B | $0.37B | 12.83% |
| 1996-09-30 | $2.75B | $0.36B | 13.01% |
| 1996-06-30 | $2.58B | $0.33B | 12.94% |
| 1996-03-31 | $2.36B | $0.32B | 13.49% |
| 1995-12-31 | $2.21B | $0.30B | 13.54% |
| 1995-09-30 | $2.01B | $0.27B | 13.28% |
| 1995-06-30 | $1.89B | $0.23B | 12.35% |
| 1995-03-31 | $1.79B | $0.22B | 12.26% |
| 1994-12-31 | $1.69B | $0.21B | 12.17% |
| 1994-09-30 | $1.60B | $0.18B | 11.27% |
| 1994-06-30 | $1.47B | $0.17B | 11.57% |
| 1994-03-31 | $1.34B | $0.15B | 11.04% |
| 1993-12-31 | $1.25B | $0.13B | 10.41% |
| 1993-09-30 | $1.20B | $0.13B | 10.56% |
| 1993-06-30 | $1.13B | $0.11B | 9.93% |
| 1993-03-31 | $1.04B | $0.11B | 10.31% |
| 1992-12-31 | $0.95B | $0.10B | 10.75% |
| 1992-09-30 | $0.89B | $0.10B | 11.30% |
| 1992-06-30 | $0.83B | $0.09B | 11.15% |
| 1992-03-31 | $0.82B | $0.08B | 10.27% |
| 1991-12-31 | $0.81B | $0.08B | 9.80% |
| 1991-09-30 | $0.82B | $0.07B | 8.89% |
| 1991-06-30 | $0.81B | $0.07B | 8.64% |
| 1991-03-31 | $0.78B | $0.06B | 8.22% |
| 1990-12-31 | $0.72B | $0.06B | 8.19% |
| 1990-09-30 | $0.69B | $0.05B | 7.42% |
| 1990-06-30 | $0.64B | $0.04B | 6.57% |
| 1990-03-31 | $0.62B | $0.04B | 6.46% |
| 1989-12-31 | $0.62B | $0.04B | 6.26% |
| 1989-09-30 | $0.61B | $0.04B | 6.44% |
| 1989-06-30 | $0.60B | $0.04B | 6.18% |
| 1989-03-31 | $0.57B | $0.04B | 6.15% |
| 1988-12-31 | $0.54B | $0.03B | 6.17% |
| 1988-09-30 | $0.45B | $0.03B | 6.29% |
| 1988-06-30 | $0.42B | $0.03B | 6.27% |
| 1988-03-31 | $0.39B | $0.03B | 6.36% |
| 1987-12-31 | $0.38B | $0.03B | 6.53% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $217.426B | $42.879B |
| Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $196.987B | 77.07 |
| IDEXX Laboratories (IDXX) | United States | $55.092B | 54.71 |
| Edwards Lifesciences (EW) | United States | $50.080B | 33.58 |
| Alcon (ALC) | Switzerland | $38.300B | 25.88 |
| IQVIA Holdings (IQV) | United States | $37.570B | 20.95 |
| Mettler-Toledo (MTD) | United States | $28.662B | 33.53 |
| STERIS (STE) | Ireland | $25.362B | 26.18 |
| DexCom (DXCM) | United States | $22.644B | 31.22 |
| Waters (WAT) | United States | $22.588B | 29.87 |
| Hologic (HOLX) | United States | $16.492B | 17.37 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.115B | 0.00 |
| Globus Medical (GMED) | United States | $11.303B | 23.72 |
| Penumbra (PEN) | United States | $10.968B | 77.15 |
| Masimo (MASI) | United States | $8.117B | 26.01 |
| Sysmex ADR (SSMXY) | Japan | $6.351B | 20.18 |
| Glaukos (GKOS) | United States | $5.171B | 0.00 |
| Teleflex (TFX) | United States | $4.729B | 7.54 |
| TransMedics (TMDX) | United States | $3.930B | 46.56 |
| Veracyte (VCYT) | United States | $3.111B | 35.45 |
| LivaNova (LIVN) | United Kingdom | $3.023B | 16.33 |
| Alphatec Holdings (ATEC) | United States | $2.932B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.435B | 11.43 |
| Artivion (AORT) | United States | $2.165B | 99.35 |
| Nihon Kohden (NHNKY) | Japan | $2.021B | 17.64 |
| Elekta AB (EKTAY) | Sweden | $1.737B | 16.83 |
| PROCEPT BioRobotics (PRCT) | United States | $1.659B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.262B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.197B | 0.00 |
| AxoGen (AXGN) | United States | $1.086B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.12 |
| OPKO Health (OPK) | United States | $0.983B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.976B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.915B | 4.96 |
| SiBone (SIBN) | United States | $0.756B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.592B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.529B | 30.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.529B | 10.55 |
| AngioDynamics (ANGO) | United States | $0.499B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.486B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.439B | 0.00 |
| NeuroPace (NPCE) | United States | $0.431B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.419B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.408B | 11.27 |
| RxSight (RXST) | United States | $0.400B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.376B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.331B | 2.49 |
| Delcath Systems (DCTH) | United States | $0.315B | 52.53 |
| Alpha Tau Medical (DRTS) | Israel | $0.315B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| CVRx (CVRX) | United States | $0.243B | 0.00 |
| 908 Devices (MASS) | United States | $0.198B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.193B | 0.00 |
| Inogen (INGN) | United States | $0.187B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.187B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.152B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.147B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.139B | 0.00 |
| Neuronetics (STIM) | United States | $0.136B | 0.00 |
| LENSAR (LNSR) | United States | $0.121B | 0.00 |
| Accuray (ARAY) | United States | $0.118B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.103B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.090B | 0.00 |
| InspireMD (NSPR) | United States | $0.089B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.075B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 0.00 |
| Spectral AI (MDAI) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.045B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.016B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.008B | 0.00 |
| Solana (HSDT) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.25 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |